The global viral vector production industry was valued at US$ 16.7 billion in 2022. The market is anticipated to expand at a CAGR of 4.4% from 2023 to 2031 and is projected to reach more than US$ 17.3 billion by 2031. Increasing demand for gene therapy, vaccine development, and advanced biologic treatments is driving market growth globally. Viral vectors play a critical role in delivering...